The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
600
The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Alabama Clinical Therapuetics, LLC, 52 Medical Park East Drive, Suite 214
Birmingham, Alabama, United States
MedCenter, 6651 Madison Ave.
Carmichael, California, United States
Torrance Clinical Research, 3640 Lomita Blfd #205
Torrance, California, United States
Clinicos, LLC
Colorado Springs, Colorado, United States
Longmont Clinic, P.C., 1925 W. Mountain View Ave.
Longmont, Colorado, United States
Front Range Clinical Research
Wheat Ridge, Colorado, United States
Dawsonville Family Medicine Clinical Trials, 5983 Hwy, 53E. Ste 175
Dawsonville, Georgia, United States
Koch Family Medicine, 81A E. Queenwood Rd.
Morton, Illinois, United States
Welborn Clinic Gateway, 4233 Gateway Blvd
Newburgh, Indiana, United States
Sterling Research Group, Ltd., 650 Sprucewood Lane
Erlanger, Kentucky, United States
...and 18 more locations